NCT02852798 2016-08-03Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLCJiangsu ShengDiYa Medicine Co., Ltd.Unknown60 enrolled